Literature DB >> 9466602

Multifocal motor neuropathy without overt conduction block.

A S Pakiam1, G J Parry.   

Abstract

One of the defining electrophysiological characteristics of multifocal motor neuropathy (MMN) is focal motor nerve conduction block. We have noted occasional patients with typical clinical features of MMN in whom there is no demonstrable conduction block. Upon review of 5 such cases, we conclude that otherwise typical MMN may present without overt conduction block. This subset of patients does not otherwise differ from patients with MMN in whom this hallmark electrodiagnostic feature is present.

Entities:  

Mesh:

Year:  1998        PMID: 9466602     DOI: 10.1002/(sici)1097-4598(199802)21:2<243::aid-mus14>3.0.co;2-2

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

2.  On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy.

Authors:  Dirk Fischer; Christoph Grothe; Stephan Schmidt; Rolf Schröder
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

3.  Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

Authors:  E Nobile-Orazio; A Cappellari; N Meucci; M Carpo; F Terenghi; A Bersano; A Priori; S Barbieri; G Scarlato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 4.  Immunoglobulin for multifocal motor neuropathy.

Authors:  Stephen Keddie; Filip Eftimov; Leonard H van den Berg; Ruth Brassington; Rob J de Haan; Ivo N van Schaik
Journal:  Cochrane Database Syst Rev       Date:  2022-01-11

Review 5.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

Review 6.  Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

Authors:  T Umapathi; Richard A C Hughes; Eduardo Nobile-Orazio; Jean-Marc Léger
Journal:  Cochrane Database Syst Rev       Date:  2015-03-04

7.  Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM.

Authors:  Jonathan S. Katz; David S. Saperstein
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

8.  Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy.

Authors:  Satish V Khadilkar; Shrikant S Deshmukh; Pramod D Dhonde
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

9.  Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies.

Authors:  Masanobu Tanemoto; Shin Hisahara; Kazuna Ikeda; Kazuki Yokokawa; Tatsuo Manabe; Reiko Tsuda; Daisuke Yamamoto; Takashi Matsushita; Akihiro Matsumura; Syuuichirou Suzuki; Shun Shimohama
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

Review 10.  Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment.

Authors:  Victoria H Lawson; W David Arnold
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-05       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.